Navigation Links
GSI Group Inc. Announces John Roush to Become Chief Executive Officer
Date:11/17/2010

BEDFORD, Mass., Nov. 17, 2010 /PRNewswire-FirstCall/ -- GSI Group Inc. (Pink Sheets: LASR) (the "Company" or "GSI") today announced that John Roush agreed to join GSI as its next Chief Executive Officer. Mr. Roush, 45, joins GSI after a successful 12-year career with PerkinElmer, Inc., where he was a corporate officer and served in several senior leadership positions, most recently as president of PerkinElmer's Environmental Health business. After a brief transition period, during which he will serve in an advisory capacity, Mr. Roush will become GSI's Chief Executive Officer by early 2011, succeeding Michael E. Katzenstein, who has served as the Company's interim principal executive officer since May 2010. The move successfully completes the strategic initiative announced on September 9, 2010 to recruit a permanent Chief Executive Officer for the Company.

"We are extremely pleased to have attracted an executive of John's caliber and experience to lead GSI's development and chart its growth strategy for the future," said Stephen W. Bershad, GSI's Chairman of the Board. "John is uniquely suited to lead our company and to extend GSI's worldwide market and product expansion. We are excited about the future and look forward to John's contributions in shaping our business," added Bershad.  

"I am excited for this opportunity to join the GSI team and to lead the organization as it scales its operations to address new market opportunities," said Mr. Roush. "The company's strong proprietary technology base, established industry partners and customers and large target markets provide a solid foundation from which to build a highly valuable, industry leading company."

Since 2009, Mr. Roush has been serving as president of PerkinElmer's Environmental Health business, accounting for approximately $1.1 billion of PerkinElmer's annual revenues. From 2004 to 2009, Mr. Roush led PerkinElmer's Optoelectronics business unit, which supplies specialty photonics products to biomedical and industrial OEMs. From 1999 to 2004, Mr. Roush served in various general management roles within the Optoelectronics business unit. Prior to joining PerkinElmer, Mr. Roush held management positions with Outboard Marine Corporation, AlliedSignal, Inc., now Honeywell International, McKinsey & Company Inc. and General Electric.

Mr. Roush holds a Bachelor of Science degree in electrical engineering from Tufts University and a Master of Business Administration from Harvard Business School.

About GSI Group Inc. GSI Group Inc. supplies precision technology to the global medical, electronics, and industrial markets and semiconductor systems. GSI Group Inc.'s common shares are quoted on Pink OTC Markets Inc. (LASR.PK).

More information about GSI is available on the company's website at www.gsig.com.

Safe Harbor and Forward Looking Information Certain statements in this release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on current expectations and assumptions that are subject to risks and uncertainties. All statements contained in this news release that do not relate to matters of historical fact should be considered forward-looking statements, and are generally identified by words such as "expect," "intend," "anticipate," "estimate," "plan," and other similar expressions. These forward-looking statements include, but are not limited to, statements related to: the Company's worldwide market and product expansion; the scaling of the Company's operations to address new market opportunities; the Company's belief about its market opportunities;  the Company's optimism regarding its prospects for the future; and other statements that are not historical facts.

These forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could affect future results and cause actual results and events to differ materially from historical and expected results and those expressed or implied in the forward-looking statements, including, but not limited to, the following: the potential adverse impact of the Company's recently completed Chapter 11 bankruptcy proceedings on the Company's business, financial condition or results of operations; the potential adverse impact of the SEC's formal investigation relating to its review of the Company's accounting practices and the restatement of the Company's historical consolidated financial statements; the highly unpredictable nature of the semiconductor and electronics materials processing industry; the Company's ability to manage its significant indebtedness in light of current economic and business conditions; the Company's ability to grow and increase profitability; the Company's ability to quickly increase manufacturing capacity and promptly respond to fluctuating product demands; the Company's need to invest in research and development; the Company's ability to develop and deliver new competitive technology and enhancements and customer acceptance thereof; the effects of competition; the Company's ability to identify and hire permanent senior management; the Company's failure to identify and manage weaknesses in internal controls; the Company's ability to complete its restatement and complete and file its delayed periodic reports with the SEC and its ability to file timely with the SEC in the future; the incurrence of additional material obligations as part of the Chapter 11 restructuring; and the Company's ability to convert bookings and backlog into shipments or revenue, as they are subject to termination or cancellation under certain circumstances. Other important risk factors that could affect the outcome of the events set forth in these statements and that could affect the Company's operating results and financial condition are discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, the Company's Current Report on Form 8-K filed on June 4, 2010, and in the Company's subsequent filings with the SEC made prior to or after the date hereof. Such statements are based on the Company's management's beliefs and assumptions and on information currently available to the Company's management. The Company disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document except as required by law. For more information contact: GSI Group Investor Relations Telephone: (781) 266-5137 Email: InvestorRelations@gsig.com
'/>"/>

SOURCE GSI Group Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hanger Orthopedic Group, Inc. Announces Expiration of Offer to Purchase Outstanding 10 1/4% Senior Notes Due 2014
2. Environmental Tectonics Corporations Sterilization Systems Group Awarded Major Contract
3. Questcor to Present at the Maxim Group Growth Conference
4. New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
5. Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group
6. DUSA Pharmaceuticals to Present at the 4th Annual Maxim Group Growth Conference
7. New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group
8. Cynosure to Present at 4th Annual Maxim Group Growth Conference
9. Systech International and Vantage Consulting Group Partner to Address Emerging U.S. Pharmaceutical Regulatory Requirements
10. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
11. Medrium Awarded Electronic Health Record (EHR) Module Certification by Drummond Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... SEOUL, South Korea , Oct. 4, 2017 /PRNewswire/ ... launched its next-generation CPR training aide "cprCUBE" on Kickstarter. ... of chest compression during cardiac arrests with better efficiency ... patient-mannequins. It also offers real-time feedback on efficacy of ... The crowdfunding campaign has a goal to raise ...
Breaking Medicine Technology:
(Date:10/13/2017)... RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... annual Holly Day Market. Featuring a collection of specialty vendors and unique items from ... of personalized and quality-focused health and wellness services offered by the VNA. The ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):